Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Boundless Bio Inc.

    NASDAQ: BOLD · Real-Time Price · USD
    1.03
    -0.04 (-3.74%)
    At close: Jun 27, 2025, 3:59 PM
    1.01
    -2.42%
    After-hours: Jun 27, 2025, 05:50 PM EDT

    Boundless Bio Statistics

    Share Statistics

    Boundless Bio has 22.39M shares outstanding. The number of shares has increased by 0.2% in one year.

    Shares Outstanding

    n/a
    		 22.39M

    Shares Change (YoY)

    n/a
    		 0.2%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 58.25%

    Shares Floating

    n/a
    		 14.94M

    Failed to Deliver (FTD) Shares

    n/a
    		 11,340

    FTD / Avg. Volume

    n/a
    		 8.69%

    Short Selling Information

    The latest short interest is 482.38K, so 2.15% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 482.38K

    Short % of Shares Out

    n/a
    		 2.15%

    Short % of Float

    n/a
    		 3.77%

    Short Ratio (days to cover)

    n/a
    		 4.62

    Valuation Ratios

    The PE ratio is -0.75 and the forward PE ratio is -0.43. Boundless Bio's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -0.75

    Forward PE

    n/a
    		 -0.43

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.8

    PB Ratio

    n/a
    		 0.33

    P/FCF Ratio

    n/a
    		 -0.78

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Boundless Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 18.98, with a Debt / Equity ratio of 0.32.

    Current Ratio

    n/a
    		 18.98

    Quick Ratio

    n/a
    		 18.98

    Debt / Equity

    n/a
    		 0.32

    Debt / EBITDA

    n/a
    		 -0.74

    Debt / FCF

    n/a
    		 -0.75

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,021,296.88

    Employee Count

    n/a
    		 64

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -76.65% in the last 52 weeks. The beta is -0.81, so Boundless Bio's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.81

    52-Week Price Change

    n/a
    		 -76.65%

    50-Day Moving Average

    n/a
    		 1.35

    200-Day Moving Average

    n/a
    		 2.24

    Relative Strength Index (RSI)

    n/a
    		 38.4

    Average Volume (20 Days)

    n/a
    		 130,535

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -73.27M

    Net Income

    n/a
    		 -65.36M

    EBITDA

    n/a
    		 -64.28M

    EBIT

    n/a
    		 -65.36M

    Earnings Per Share (EPS)

    n/a
    		 -3.85
    Full Income Statement

    Balance Sheet

    The company has 26.59M in cash and 47.63M in debt, giving a net cash position of -21.05M.

    Cash & Cash Equivalents

    n/a
    		 26.59M

    Total Debt

    n/a
    		 47.63M

    Net Cash

    n/a
    		 -21.05M

    Retained Earnings

    n/a
    		 -201.47M

    Total Assets

    n/a
    		 191.24M

    Working Capital

    n/a
    		 134.03M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -60.84M and capital expenditures -2.54M, giving a free cash flow of -63.38M.

    Operating Cash Flow

    n/a
    		 -60.84M

    Capital Expenditures

    n/a
    		 -2.54M

    Free Cash Flow

    n/a
    		 -63.38M

    FCF Per Share

    n/a
    		 -3.73
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    BOLD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BOLD is $4, which is 277.4% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $4

    Price Target Difference

    n/a
    		 277.4%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -1.73

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist